Clinical Trial Update: Eltrombopag Phase III Study In Chinese Chronic ITP Patients [Phase 3]

View source ↗

Summary

Phase III trial update for eltrombopag in Chinese chronic idiopathic thrombocytopenic purpura (ITP) patients; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Itp

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Purpura, Thrombocytopenic, Idiopathic and Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2015-03-09